HK YUMO INTERNATIONAL TRADE CO., LIMITED – Trademark Portfolio

Entity Type: 16

HK YUMO INTERNATIONAL TRADE CO., LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include YUMOYI SPRUCE JIYIN. The owner is based in North Point, Hong Kong.

15th Floor, Building 03,

CarnivalCommercial Building,18Java Road,

North Point, Hong Kong 999077 , HK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HK YUMO INTERNATIONAL TRADE CO., LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does HK YUMO INTERNATIONAL TRADE CO., LIMITED have?

HK YUMO INTERNATIONAL TRADE CO., LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does HK YUMO INTERNATIONAL TRADE CO., LIMITED file in?

HK YUMO INTERNATIONAL TRADE CO., LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HK YUMO INTERNATIONAL TRADE CO., LIMITED's most well-known trademarks?

HK YUMO INTERNATIONAL TRADE CO., LIMITED's registered trademark portfolio includes well-known marks such as YUMOYI SPRUCE JIYIN. These are among 1 currently registered trademark in the portfolio.

What is HK YUMO INTERNATIONAL TRADE CO., LIMITED's trademark registration success rate?

HK YUMO INTERNATIONAL TRADE CO., LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.